← Leaderboards
Jessica L. Macdonald
Syracuse University
$2,051,750
Attributed
$2,051,750
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $328.1K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,051,750 · 2
By mechanism
R01$1,640,625 · 1
R21$411,125 · 1
Top collaborators
No co-investigators on record.
Most similar at Syracuse University
Same institution · by research overlap
- Geraldine K Gay$2,744,115
- Matthew Cleary$229,921
- Shalabh C Maroo$995,137
Others in their field
Other Emerging Leaders on “In Vitro”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Leonard Freedmand · Leidos Biomedical Research, Inc.$68,796,314
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
- John Damon Chodera · Sloan-Kettering Inst Can Research$34,949,884
- Tony Moody · Duke University$34,777,314
Research focus
In VitroCharacteristicsGenetic TranscriptionNeuronsPathway InteractionsKnockout MiceFunctional DisorderGeneticIn VivoNeurodevelopmental DisorderPhenotypeTranscriptomeAutism Spectrum DisorderLoss Of FunctionBrainComplexBehaviorGenesLeadBoysBirthAdultAttenuationDietary Supplementation
Grant awards (7)
Unraveling the interplay between the transcriptional co-regulator Cited2 and maternal folic acid in the regulation of neocortical development$186,875
R21 · FY2025 · HD · contact PI
Unraveling the interplay between the transcriptional co-regulator Cited2 and maternal folic acid in the regulation of neocortical development$224,250
R21 · FY2024 · HD · contact PI
Restoration of Homeostasis of Downstream Targets of MeCP2 as a Potential Therapeutic Avenue for Rett Syndrome$328,125
R01 · FY2023 · NS · contact PI
Restoration of Homeostasis of Downstream Targets of MeCP2 as a Potential Therapeutic Avenue for Rett Syndrome$328,125
R01 · FY2022 · NS · contact PI
Restoration of Homeostasis of Downstream Targets of MeCP2 as a Potential Therapeutic Avenue for Rett Syndrome$328,125
R01 · FY2021 · NS · contact PI
Restoration of Homeostasis of Downstream Targets of MeCP2 as a Potential Therapeutic Avenue for Rett Syndrome$328,125
R01 · FY2020 · NS · contact PI
Restoration of Homeostasis of Downstream Targets of MeCP2 as a Potential Therapeutic Avenue for Rett Syndrome$328,125
R01 · FY2019 · NS · contact PI